insulin aspart

FDA Drug Profile — NOVOLOG, Insulin Aspart, NOVOLOG MIX 70/30, NovoLog Mix 70/30, .Insulin Aspart Protamine and Insulin Aspart

insulin aspart is listed in the FDA National Drug Code directory with 27 NDC codes, marketed under brand names including NOVOLOG, Insulin Aspart, NOVOLOG MIX 70/30. Available dosage forms: injection, solution, injection, suspension.

Drug Details

Generic Name
insulin aspart
Brand Names
NOVOLOG, Insulin Aspart, NOVOLOG MIX 70/30, NovoLog Mix 70/30, .Insulin Aspart Protamine and Insulin Aspart, Insulin Aspart Protamine and Insulin Aspart Mix 70/30, Fiasp
Application Number
BLA020986
Sponsor
Novo Nordisk
NDC Codes
27
Dosage Forms
INJECTION, SOLUTION, INJECTION, SUSPENSION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN ASPART

Indications and Usage

1 INDICATIONS AND USAGE Insulin Aspart is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Insulin Aspart is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).